TELA BIO, INC. (TELA): Price and Financial Metrics


TELA BIO, INC. (TELA)

Today's Latest Price: $16.03 USD

0.86 (5.67%)

Updated Dec 3 12:29pm

Add TELA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

TELA Stock Summary

  • TELA's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.47 -- higher than only 6.11% of US-listed equities with positive expected earnings growth.
  • TELA's went public 1.07 years ago, making it older than just 0.6% of listed US stocks we're tracking.
  • TELA Bio Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -43.63%, greater than the shareholder yield of only 8.21% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to TELA Bio Inc, a group of peers worth examining would be XGN, STIM, ESTA, VAPO, and ARTW.
  • Visit TELA's SEC page to see the company's official filings. To visit the company's web site, go to www.telabio.com.

TELA Stock Price Chart Interactive Chart >

Price chart for TELA

TELA Price/Volume Stats

Current price $16.03 52-week high $23.55
Prev. close $15.17 52-week low $5.25
Day low $15.31 Volume 1,407
Day high $16.34 Avg. volume 57,383
50-day MA $16.22 Dividend yield N/A
200-day MA $13.93 Market Cap 231.34M

TELA BIO, INC. (TELA) Company Bio


TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.


TELA Latest News Stream


Event/Time News Detail
Loading, please wait...

TELA Latest Social Stream


Loading social stream, please wait...

View Full TELA Social Stream

Latest TELA News From Around the Web

Below are the latest news stories about TELA Bio Inc that investors may wish to consider to help them evaluate TELA as an investment opportunity.

Additional data shows durable outcome for TELA Bio' tissue matrix for hernia repair

TELA Bio (TELA) has announced additional data from its BRAVO study with OviTex tissue matrix. Data were presented at the Americas Hernia Society Annual Meeting.30-day data from 85 subjects demonstrated that ventral hernia repair using OviTex resulted in low incidence of surgical site infections and occurrences. None (0%) patient experienced a hernia recurrence within...

Seeking Alpha | September 25, 2020

TELA Bio, Inc. (TELA) CEO Tony Koblish on Q2 2020 Results - Earnings Call Transcript

TELA Bio, Inc. (TELA) Q2 2020 Earnings Conference Call August 12, 2020 4:30 PM ET Company Participants Stuart Henderson - Vice President, Corporate Development & Investor Relations Tony Koblish - President & Chief Executive Officer Nora Brennan - Chief Financial Officer. Conference Call Participants Raj Denhoy - Jefferies Matthew O'Brien...

SA Transcripts on Seeking Alpha | August 13, 2020

TELA Bio Announces Second Quarter 2020 Financial Results

MALVERN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on…

GlobeNewswire | August 12, 2020

TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announces today it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020. TELA Bio's management is scheduled to present on Thursday, August 13, 2020, at 1:30 p.m. Eastern Time. Interested parties may access a live audio webcast of the presentation by visiting the "Investors" section of the company's website at ir.telabio.com. About TELA Bio, Inc.TELA Bio, Inc. is a commercial-stage medical technology compan...

Yahoo | July 30, 2020

TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020

MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that the company will report 2020 second quarter financial results on August 12, 2020. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.  Conference Call and Webcast Details The conference call can be accessed by dialing (855) 548-1219 for participants in the U.S. or Canada and (409) 217-8881 for international callers, using conference ID 6897439. A live and archived webcast of ...

Yahoo | July 23, 2020

Read More 'TELA' Stories Here

TELA Price Returns

1-mo -1.11%
3-mo 21.53%
6-mo -2.85%
1-year 21.99%
3-year N/A
5-year N/A
YTD 23.78%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7588 seconds.